2021

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization

O'Quinn, R., Ferrari, V. A., Daly, R., Hundley, G., Baldassarre, L. A., Han, Y., Barac, A., & Arnold, A. (2021). Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization. JACC. CardioOncology, 3(2), 191–200. https://doi.org/10.1016/j.jaccao.2021.04.011

An Approach to Faculty Development for Underrepresented Minorities in Medicine

Robles, J., Anim, T., Wusu, M. H., Foster, K. E., Parra, Y., Amaechi, O., Allen, K. C., Rodríguez, J. E., Campbell, K. M., Tumin, D., & Washington, J. (2021). An Approach to Faculty Development for Underrepresented Minorities in Medicine. Southern Medical Journal, 114(9), 579–582. https://doi.org/10.14423/SMJ.0000000000001290

Framework for Considering Abnormal Heart Rate Characteristics and Other Signs of Sepsis in Very Low Birth Weight Infants

Kumar, R. S., Otero, N. A., Abubakar, M. O., Elliott, M. R., Wiggins, J. Y., Sharif, M. M., Sullivan, B. A., & Fairchild, K. D. (2021). Framework for Considering Abnormal Heart Rate Characteristics and Other Signs of Sepsis in Very Low Birth Weight Infants. American Journal of Perinatology, 10.1055/a-1715-3727. Advance online publication. https://doi.org/10.1055/a-1715-3727

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection

Zasowski, E. J., Trinh, T. D., Claeys, K. C., Lagnf, A. M., Bhatia, S., Klinker, K. P., Veve, M. P., Estrada, S. J., Johns, S. T., Sawyer, A. J., Huang, V., LaFrance, B., Levine, D. P., Kaye, K. S., Davis, S. L., & Rybak, M. J. (2021). Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open Forum Infectious Diseases, 9(3), ofab606. https://doi.org/10.1093/ofid/ofab606

What Is Your Risk Adjustment Factor? Documenting Disease Burden, Hierarchical Condition Categories to Optimize Revenue in Value-Based Payment Models

Prasad, V. L., McGuire, B., Lynch, L., Mainous, T., & Fay, K. M. (2021). What Is Your Risk Adjustment Factor? Documenting Disease Burden, Hierarchical Condition Categories to Optimize Revenue in Value-Based Payment Models. Journal of Medical Practice Management, 36(5), 260–265.

The High-value Pharmacy Enterprise Framework: Advancing Pharmacy Practice in Health Systems Through a Consensus-based, Strategic Approach

Rough, S., Shane, R., Armitstead, J. A., Belford, S. M., Brummond, P. W., Chen, D., Collins, C. M., Dalton, H., Dopp, A. L., Estevez, M. M., Hager, D. R., Halbach, B., Hays, R., Knoer, S., Kotis, D., Montgomery, D., Plummer, B., Riester, M. R., Schreier, D. J., & Simonson, D. (2021). The high-value pharmacy enterprise framework: Advancing pharmacy practice in health systems through a consensus-based, strategic approach. American Journal of Health-System Pharmacy, 78(6), 498–510.